Document Detail

Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes.
MedLine Citation:
PMID:  21964667     Owner:  NLM     Status:  Publisher    
The acute obstruction of pulmonary vessels by venous thrombi is a critical condition named acute pulmonary embolism (APE). During massive APE, severe pulmonary hypertension may lead to death secondary to right heart failure and circulatory shock. APE-induced pulmonary hypertension is aggravated by active pulmonary vasoconstriction. While blocking the effects of some vasoconstrictors exerts beneficial effects, no previous study has examined whether angiotensin II receptor blockers protect against the hemodynamic changes associated with APE. We examined the effects exerted by losartan on APE-induced hemodynamic changes. Hemodynamic evaluations were performed in non-embolized lambs treated with saline (n = 4) and in lambs that were embolized with silicon microspheres and treated with losartan (30 mg/kg followed by 1 mg/kg/h, n = 5) or saline (n = 7) infusions. The plasma and lung angiotensin-converting enzyme (ACE) activity were assessed using a fluorometric method. APE increased mean pulmonary arterial pressure (MPAP) and pulmonary vascular resistance index (PVRI) by 21 ± 2 mmHg and 375 ± 20 dyn s cm(-5) m(-2), respectively (P < 0.05). Losartan decreased MPAP significantly (by approximately 15%), without significant changes in PVRI and tended to decrease cardiac index (P > 0.05). Lung and plasma ACE activity were similar in both embolized and non-embolized animals. Our findings show evidence of lack of activation of the renin-angiotensin system during APE. The lack of significant effects of losartan on the pulmonary vascular resistance suggests that losartan does not protect against the hemodynamic changes found during APE.
Carlos A Dias-Junior; Evandro M Neto-Neves; Marcelo F Montenegro; Jose E Tanus-Santos
Related Documents :
21964667 - Losartan exerts no protective effects against acute pulmonary embolism-induced hemodyna...
2816707 - Prevalence and mechanisms of mitral regurgitation in the absence of intrinsic abnormali...
7247327 - Two dimensional echocardiography in valvular heart disease.
9176317 - Physical and physiological determinants of pulmonary venous flow: numerical analysis.
1607087 - Incidence and risk factors for biliary and pancreatic stent migration.
23253927 - Large-vessel involvement in giant cell arteritis: a population-based cohort study of th...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-2
Journal Detail:
Title:  Naunyn-Schmiedeberg's archives of pharmacology     Volume:  -     ISSN:  1432-1912     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0326264     Medline TA:  Naunyn Schmiedebergs Arch Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Pharmacology, Campus Centro-Oeste Dona Lindu, Federal University of Sao Joao Del Rei, Rua Sebastiao Goncalves Coelho, 400, 35501-296, Divinopolis, MG, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Complementary anti-inflammatory effects of a ?-blocker and a corticosteroid in an asthma model.
Next Document:  Reducing the Framing Effect in Older and Younger Adults by Encouraging Analytic Processing.